Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001140361-21-022785

Options or other derivatives

  • Director acquired 31,274 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
RAAB MICHAEL Director 2021-06-25 Grant or award · Stock Option (Right to Buy) +16,784 16,784 D
RAAB MICHAEL Director 2021-06-25 Grant or award · Stock Option (Right to Buy) +9,660 9,660 D
RAAB MICHAEL Director 2021-06-25 Grant or award · Stock Option (Right to Buy) +4,830 4,830 D
Loading xslF345X03/form4.xml…